• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

亚太肝脏研究学会（APASL）和美国肝病研究学会（AASLD）肝细胞癌影像诊断共识指南：综述

APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review.

作者信息

Tan Cher Heng, Low Su-Chong Albert, Thng Choon Hua

机构信息

Department of Diagnostic Radiology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433.

出版信息

Int J Hepatol. 2011;2011:519783. doi: 10.4061/2011/519783. Epub 2011 Apr 19.

DOI:10.4061/2011/519783
PMID:22007313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3170828/
Abstract

Consensus guidelines for radiological diagnosis of hepatocellular carcinoma (HCC) have been drafted by several large international working groups. This article reviews the similarities and differences between the most recent guidelines proposed by the American Association for Study of Liver Diseases and the Asian Pacific Association for the Study of the Liver. Current evidence for the various imaging modalities for diagnosis of HCC and their relevance to the consensus guidelines are reviewed.

摘要

几个大型国际工作组已经起草了肝细胞癌（HCC）的放射学诊断共识指南。本文回顾了美国肝病研究协会和亚太肝病研究协会提出的最新指南之间的异同。文中还对用于诊断HCC的各种成像方式的现有证据及其与共识指南的相关性进行了综述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88c9/3170828/60828ae4cd9e/IJHEP2011-519783.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88c9/3170828/3dd56eeb3338/IJHEP2011-519783.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88c9/3170828/8b8bd28f9891/IJHEP2011-519783.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88c9/3170828/60828ae4cd9e/IJHEP2011-519783.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88c9/3170828/3dd56eeb3338/IJHEP2011-519783.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88c9/3170828/8b8bd28f9891/IJHEP2011-519783.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88c9/3170828/60828ae4cd9e/IJHEP2011-519783.003.jpg

相似文献

1
APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review.亚太肝脏研究学会（APASL）和美国肝病研究学会（AASLD）肝细胞癌影像诊断共识指南：综述
Int J Hepatol. 2011;2011:519783. doi: 10.4061/2011/519783. Epub 2011 Apr 19.
2
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma.肝细胞癌非侵入性诊断国际指南比较
Liver Cancer. 2012 Nov;1(3-4):190-200. doi: 10.1159/000343833.
3
Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid-enhanced MRI in transplantation candidates.移植候选者使用钆塞酸增强 MRI 诊断肝细胞癌的指南比较。
Eur Radiol. 2020 Sep;30(9):4762-4771. doi: 10.1007/s00330-020-06881-y. Epub 2020 Apr 25.
4
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update.国际肝细胞癌无创诊断指南比较：2018 年更新。
Clin Mol Hepatol. 2019 Sep;25(3):245-263. doi: 10.3350/cmh.2018.0090. Epub 2019 Feb 14.
5
Resection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria?肝细胞癌切除术：将其限制在美国肝脏研究协会/巴塞罗那肝癌临床标准是否合理？
J Gastroenterol Hepatol. 2012 Mar;27(3):452-7. doi: 10.1111/j.1440-1746.2011.07034.x.
6
Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period.近十年间肝细胞癌诊断指南的变化。
Clin Mol Hepatol. 2012 Sep;18(3):258-67. doi: 10.3350/cmh.2012.18.3.258. Epub 2012 Sep 25.
7
Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid-enhanced MRI in at-risk patients.对高危患者应用钆塞酸增强 MRI 进行肝细胞癌诊断的现行指南的回顾性分析。
Eur Radiol. 2021 Jul;31(7):4751-4763. doi: 10.1007/s00330-020-07577-z. Epub 2021 Jan 3.
8
Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.国际指南识别乙型肝炎 e 抗原阴性慢性乙型肝炎患者显著纤维化的准确性。
Clin Gastroenterol Hepatol. 2013 Nov;11(11):1493-1499.e2. doi: 10.1016/j.cgh.2013.05.038. Epub 2013 Jun 28.
9
Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System.印度国家肝脏研究协会和印度放射与影像协会关于肝细胞癌诊断与成像的联合共识声明，纳入肝脏影像报告和数据系统
J Clin Exp Hepatol. 2019 Sep-Oct;9(5):625-651. doi: 10.1016/j.jceh.2019.07.005. Epub 2019 Aug 6.
10
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.亚太肝病学会肝癌共识建议。
Hepatol Int. 2010 Mar 18;4(2):439-74. doi: 10.1007/s12072-010-9165-7.

引用本文的文献

1
Value of enhancing capsule for diagnosing hepatocellular carcinoma on MRI: implications for simplifying LI-RADS.MRI增强扫描对肝细胞癌的诊断价值：对简化肝脏影像报告和数据系统（LI-RADS）的启示
Eur Radiol. 2025 Aug 22. doi: 10.1007/s00330-025-11938-x.
2
Prostate-specific membrane antigen-targeting radiopharmaceuticals: a new frontier in hepatic malignancies.前列腺特异性膜抗原靶向放射性药物：肝脏恶性肿瘤治疗的新前沿
Front Oncol. 2025 Mar 7;15:1547459. doi: 10.3389/fonc.2025.1547459. eCollection 2025.
3
Optimizing Hepatocellular Carcinoma Screening: A Comparative Simulated Abbreviated MRI Protocol Study.

本文引用的文献

1
Management of hepatocellular carcinoma: an update.肝细胞癌的管理：最新进展
Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.
2
Optimization of imaging diagnosis of 1-2 cm hepatocellular carcinoma: an analysis of diagnostic performance and resource utilization.1-2 厘米肝细胞癌影像诊断的优化：诊断性能和资源利用分析。
J Hepatol. 2011 Apr;54(4):723-8. doi: 10.1016/j.jhep.2010.07.025. Epub 2010 Sep 22.
3
New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.
优化肝细胞癌筛查：一项比较性模拟简化磁共振成像方案研究。
Cureus. 2025 Feb 7;17(2):e78711. doi: 10.7759/cureus.78711. eCollection 2025 Feb.
4
Liver diseases: epidemiology, causes, trends and predictions.肝脏疾病：流行病学、病因、趋势及预测
Signal Transduct Target Ther. 2025 Feb 5;10(1):33. doi: 10.1038/s41392-024-02072-z.
5
Diagnostic and prognostic performances of GALAD score in staging and 1-year mortality of hepatocellular carcinoma: A prospective study.GALAD 评分在肝细胞癌分期和 1 年死亡率中的诊断和预后性能：一项前瞻性研究。
World J Gastroenterol. 2024 May 7;30(17):2343-2353. doi: 10.3748/wjg.v30.i17.2343.
6
Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study.亚太地区肝细胞癌诊断、治疗与管理的真实世界数据：洞察研究
Liver Cancer. 2023 Oct 9;13(3):298-313. doi: 10.1159/000534513. eCollection 2024 Jun.
7
A high-throughput test enables specific detection of hepatocellular carcinoma.高通量检测可特异性检测肝细胞癌。
Nat Commun. 2023 Jun 7;14(1):3306. doi: 10.1038/s41467-023-39055-7.
8
Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations.Fibrosis-4指数，即使在乙肝病毒占主导的人群中，也是肝细胞癌患者根治性肝切除术后预后的一个预测指标。
Ann Surg Treat Res. 2023 Apr;104(4):195-204. doi: 10.4174/astr.2023.104.4.195. Epub 2023 Mar 31.
9
Accuracy of Non-Contrast MRI for the Detection of Hepatocellular Carcinoma: A systematic review and meta-analysis.非增强磁共振成像检测肝细胞癌的准确性：一项系统评价和荟萃分析。
Pak J Med Sci. 2022 Mar-Apr;38(3Part-I):743-750. doi: 10.12669/pjms.38.3.5142.
10
Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis.新型磷脂酰肌醇蛋白聚糖3外泌体用于检测肝硬化中肝细胞癌的实验验证
J Hepatocell Carcinoma. 2021 Dec 8;8:1579-1596. doi: 10.2147/JHC.S327339. eCollection 2021.
新型磁共振成像扩散加权序列标准在慢性肝病中的肝细胞癌诊断中的应用。
J Hepatol. 2011 Jul;55(1):126-32. doi: 10.1016/j.jhep.2010.10.023. Epub 2010 Nov 23.
4
Evaluation of hepatocellular carcinoma using contrast-enhanced ultrasonography: correlation with microvessel morphology.使用超声造影评估肝细胞癌：与微血管形态的相关性。
Hepatobiliary Pancreat Dis Int. 2010 Dec;9(6):605-10.
5
Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration.肝内实质性富血供病灶：使用钆贝葡胺行增强动态及肝胆期磁共振成像后的准确诊断——真正的良性病变。
Invest Radiol. 2011 Apr;46(4):225-39. doi: 10.1097/RLI.0b013e3181feee3a.
6
Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout.多排螺旋 CT 检测肝硬化患者肝细胞癌：肝静脉期与延迟期对肿瘤洗脱的检测
Br J Radiol. 2011 May;84(1001):403-12. doi: 10.1259/bjr/18329080. Epub 2010 Nov 16.
7
Validation of an extension of the international non-invasive criteria for the diagnosis of hepatocellular carcinoma to the characterization of macroscopic portal vein thrombosis.验证将国际非侵入性诊断肝细胞癌标准扩展用于宏观门静脉血栓形成的特征描述的有效性。
J Gastroenterol Hepatol. 2011 Apr;26(4):669-77. doi: 10.1111/j.1440-1746.2010.06564.x.
8
Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease.正电子发射断层扫描/计算机断层扫描（PET/CT）探测肝细胞癌：肝硬化或慢性肝病患者氟代胆碱 18F 和氟代脱氧葡萄糖 18F-FDG 的前瞻性比较。
J Nucl Med. 2010 Nov;51(11):1699-706. doi: 10.2967/jnumed.110.075507. Epub 2010 Oct 18.
9
CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.CT 和 MRI 比单独的超声检查能更有效地检测出肝硬化患者的肝癌。
Clin Gastroenterol Hepatol. 2011 Feb;9(2):161-7. doi: 10.1016/j.cgh.2010.09.017. Epub 2010 Oct 1.
10
Improved diagnosis of well-differentiated hepatocellular carcinoma with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid-enhanced magnetic resonance imaging and Sonazoid contrast-enhanced ultrasonography.钆塞酸二乙三胺五乙酸增强磁共振成像和 SonoVue 超声造影在诊断高分化肝细胞癌中的作用。
Hepatol Res. 2010 Sep;40(9):930-6. doi: 10.1111/j.1872-034X.2010.00697.x.